Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

Blood (2021) 138 (Supplement 1): 2448.

https://doi.org/10.1182/blood-2021-154490

Published: 2021

Journal Articles

CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

Krish Patel, Jeffrey A. Zonder, Dahlia Sano, Michael Maris, Alexander Lesokhin, Gottfried von Keudell, Catherine Lai, Rod Ramchandren, Tina Catalano, Gloria H. Y. Lin, Bob Uger, Penka S. Petrova, Naomi Molloy, Ingmar Bruns, Swaminathan P Iyer

Blood (2021) 138 (Supplement 1): 3560.

https://doi.org/10.1182/blood-2021-153683

Published: 2021

Journal Articles

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy

Fabian Zohren, Ingmar Bruns, Sabrina Pechtel, Thomas Schroeder, Roland Fenk, Akos Czibere, Georg Maschmeyer, Dorothea Kofahl-Krause, Norbert Niederle, Gerhard Heil, Christoph Losem, Manfred Welslau, Wolfram Brugger, Ulrich Germing, Ralf Kronenwett, Juergen Barth, Mathias J. Rummel, Rainer Haas, Guido Kobbe

Blood (2015) 126 (12): 1407–1414.

https://doi.org/10.1182/blood-2015-03-630012

Published: 2015

Includes: Supplemental data

Journal Articles

Megakaryocytes Regulate Hematopoietic Stem Cell Quiescence Via PF4 Secretion

Ingmar Bruns, MD, Daniel Lucas, PhD, Sandra Pinho, PhD, Jalal Ahmed, Michele P Lambert, MD, Christoph Scheiermann, PhD, Yuya Kunisaki, MD, PhD, Mortimer Poncz, MD, Paul S. Frenette, MD

Blood (2013) 122 (21): 3.

https://doi.org/10.1182/blood.V122.21.3.3

Published: 2013

Journal Articles

Bone Marrow Arteriolar Niches Maintain Hematopoietic Stem Cell Quiescence

Yuya Kunisaki, MD, PhD, Ingmar Bruns, MD, PhD, Christoph Scheiermann, PhD, Sandra Pinho, PhD, Dachuan Zhang, Paul S. Frenette, MD, FRCPC

Blood (2012) 120 (21): 638.

https://doi.org/10.1182/blood.V120.21.638.638

Published: 2012

Journal Articles

PDGFRα and CD51 Mark Human Nestin + Sphere-Forming Mesenchymal Stem Cells Capable of Robust Hematopoietic Stem Cell Expansion

Sandra Pinho, PhD, Julie Lacombe, PhD, Maher Hanoun, MD, PhD, Ingmar Bruns, MD, PhD, Yuya Kunisaki, MD, PhD, Toshihide Mizoguchi, PhD, Paul S. Frenette, MD, FRCPC

Blood (2012) 120 (21): 505.

https://doi.org/10.1182/blood.V120.21.505.505

Published: 2012

Journal Articles

Multiple myeloma–related deregulation of bone marrow–derived CD34 + hematopoietic stem and progenitor cells

Blood (2012) 120 (13): 2620–2630.

https://doi.org/10.1182/blood-2011-04-347484

Published: 2012

Includes: Supplemental data

Journal Articles

Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields

Daniel Lucas, Ingmar Bruns, Michela Battista, Simon Mendez-Ferrer, Claire Magnon, Yuya Kunisaki, Paul S. Frenette

Blood (2012) 119 (17): 3962–3965.

https://doi.org/10.1182/blood-2011-07-367102

Published: 2012

Includes: Supplemental data

Journal Articles

Analysis of Mesenchymal Stromal Cells (MSC) and Their Interactions with CD34 Stem and Progenitor Cells in Patients with Myelodysplastic Syndromes (MDS)

Stefanie Geyh, Ron Patrick Cadeddu, Julia Fröbel, Ingmar Bruns, MD, Fabian Zohren, Ali-Nuri Hünerlitürkoglu, Guido Kobbe, MD, Norbert Gattermann, MD, Ulrich Germing, MD, Rainer Haas, Thomas Schroeder, MD

Blood (2011) 118 (21): 2393.

https://doi.org/10.1182/blood.V118.21.2393.2393

Published: 2011

Journal Articles

Phase II Study of Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) As First Salvage Therapy in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Final Results From the AZARELA-Trial (NCT-00795548)

Thomas Schroeder, MD, Akos Czibere, MD, PhD, Nicolaus Kröger, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, Prof., Dr., Thomas Luft, Christine Wolschke, Ingmar Bruns, MD, Fabian Zohren, MD, Roland Fenk, Rainer Haas, MD, Prof, Guido Kobbe, MD

Blood (2011) 118 (21): 656.

https://doi.org/10.1182/blood.V118.21.656.656

Published: 2011

Journal Articles

Secondary Primary Malignancies in Patients with Multiple Myeloma Treated with High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation,

Roland Fenk, MD, Florian Neubauer, Ingmar Bruns, MD, Christian Saure, MD, Thomas Schroeder, MD, Ulrich Germing, MD, Norbert Gattermann, MD, Rainer Haas, MD, Prof, Guido Kobbe, MD

Blood (2011) 118 (21): 4087.

https://doi.org/10.1182/blood.V118.21.4087.4087

Published: 2011

Journal Articles

The Disease-Related Bone Marrow Microenvironment Alters Hematopoietic Stem and Progenitor Function in Multiple Myeloma Patients

Ingmar Bruns, MD, Ron-Patrick Cadeddu, Ines Brückmann, Sebastian Buest, Julia Fröbel, Thomas Schroeder, Stefanie Geyh, Ali-Nuri Hünerlitürkoglu, Guido Kobbe, MD, Roland Fenk, Andreas Trumpp, Akos Czibere, MD, PhD, Rainer Haas

Blood (2011) 118 (21): 2898.

https://doi.org/10.1182/blood.V118.21.2898.2898

Published: 2011

Journal Articles

Natalizumab Increases Circulating CD34+ Cells with An Impaired Functional Potential In Patients with Multiple Sclerosis without Affecting the Bone Marrow.

Christian Saure, MD, Fabian Zohren, MD, Thomas Schroeder, MD, Ingmar Bruns, MD, Ron Patrick Cadeddu, Ute Fischer, MD, Guido Kobbe, MD, Hans Peter Hartung, Bernd C Kieseier, Rainer Haas

Blood (2010) 116 (21): 2620.

https://doi.org/10.1182/blood.V116.21.2620.2620

Published: 2010

Journal Articles

Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) In Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Interim-Analysis From the AZARELA-Trial (NCT-00795548).

Thomas Schroeder, Akos Gabor Czibere, Nicolaus Kröger, Uwe Platzbecker, Gesine Bug, Kathrin Rieger, Thomas Luft, Ingmar Bruns, Fabian Zohren, Christine Wolschke, MD, Roland Fenk, Rainer Haas, Guido Kobbe, MD

Blood (2010) 116 (21): 1294.

https://doi.org/10.1182/blood.V116.21.1294.1294

Published: 2010

Journal Articles

TIMP–1 Plays a Functional Role in CD34. + Hematopoietic Stem and Progenitor Cells.

C. Matthias Wilk, Akos G. Czibere, MD, PhD, Ron-Patrick Cadeddu, Sebastian Buest, Frank A. Schildberg, Marcel A. Lauterbach, Volker Westphal, PhD, Stefan W. Hell, Prof., Rainer Haas, Prof., Ingmar Bruns, MD, PhD

Blood (2009) 114 (22): 1487.

https://doi.org/10.1182/blood.V114.22.1487.1487

Published: 2009

Journal Articles

Malignant Myeloma Cells Impair Phenotype and Function of stem and Progenitor Cells.

Ingmar Bruns, MD, PhD, Sebastian Büst, Akos G. Czibere, MD, Ron-Patrick Cadeddu, Ines Brückmann, Manoj Bhasin, Johannes C Fischer, Roland Fenk, Guido Kobbe, MD, Andreas Trumpp, Rainer Haas

Blood (2009) 114 (22): 1799.

https://doi.org/10.1182/blood.V114.22.1799.1799

Published: 2009

Journal Articles

Clinical Efficacy of Sorafenib in Patients with Acute Myeloid Leukemia (AML) and Activating FLT3-Mutations.

Thomas Schroeder, MD, Christian Saure, Ingmar Bruns, MD, PhD, Fabian Zohren, Akos G. Czibere, MD, Nelly Nancy Safaian, Roland Fenk, Rainer Haas, Guido Kobbe, MD

Blood (2009) 114 (22): 2057.

https://doi.org/10.1182/blood.V114.22.2057.2057

Published: 2009

Journal Articles

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Fabian Zohren, Ingmar Bruns, MD, PhD, Juergen Barth, Sabrina Pechtel, Roland Fenk, Thomas Schroeder, Akos G. Czibere, MD, Georg Maschmeyer, Dorothea Kofahl-Krause, Gerhard Heil, Norbert Niederle, Christoph Losem, Manfred Welslau, Ulrich Germing, Ralf Kronenwett, Rainer Haas, Mathias J Rummel, MD, PhD, Guido Kobbe, MD

Blood (2009) 114 (22): 441.

https://doi.org/10.1182/blood.V114.22.441.441

Published: 2009

Journal Articles

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

Ron-Patrick Cadeddu, Akos G. Czibere, MD, Sebastian Büst, Johannes C Fischer, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Guido Kobbe, MD, Rainer Haas, Ingmar Bruns, MD, PhD

Blood (2009) 114 (22): 4593.

https://doi.org/10.1182/blood.V114.22.4593.4593

Published: 2009

Journal Articles

A Quality of Life Study Utilizing the EORTC QLQ-30 and EORTC QLQ-HDC29 Questionnaires for the Interview of 215 Patients Who Received Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Akos G. Czibere, MD, Verena Heymann, Ingmar Bruns, MD, PhD, Thomas Schroeder, Roland Fenk, Fabian Zohren, Mustafa Kondakci, Sebastian Balleisen, Rainer Haas, Guido Kobbe, MD

Blood (2009) 114 (22): 2470.

https://doi.org/10.1182/blood.V114.22.2470.2470

Published: 2009

NARROW

Updates from Ongoing, First-in-Human Phase 1 Dose Escalation and Expansion Study of TTI-621, a Novel Biologic Targeting CD47, in Patients with Relapsed or Refractory Hematologic Malignancies

CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or Refractory Lymphoma: Update from the Ongoing First-in-Human Dose Escalation Study

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy

Megakaryocytes Regulate Hematopoietic Stem Cell Quiescence Via PF4 Secretion

Bone Marrow Arteriolar Niches Maintain Hematopoietic Stem Cell Quiescence

PDGFRα and CD51 Mark Human Nestin + Sphere-Forming Mesenchymal Stem Cells Capable of Robust Hematopoietic Stem Cell Expansion

Multiple myeloma–related deregulation of bone marrow–derived CD34 + hematopoietic stem and progenitor cells

Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields

Analysis of Mesenchymal Stromal Cells (MSC) and Their Interactions with CD34 Stem and Progenitor Cells in Patients with Myelodysplastic Syndromes (MDS)

Secondary Primary Malignancies in Patients with Multiple Myeloma Treated with High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation,

The Disease-Related Bone Marrow Microenvironment Alters Hematopoietic Stem and Progenitor Function in Multiple Myeloma Patients

Natalizumab Increases Circulating CD34+ Cells with An Impaired Functional Potential In Patients with Multiple Sclerosis without Affecting the Bone Marrow.

Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) In Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Interim-Analysis From the AZARELA-Trial (NCT-00795548).

TIMP–1 Plays a Functional Role in CD34. + Hematopoietic Stem and Progenitor Cells.

Malignant Myeloma Cells Impair Phenotype and Function of stem and Progenitor Cells.

Clinical Efficacy of Sorafenib in Patients with Acute Myeloid Leukemia (AML) and Activating FLT3-Mutations.

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

A Quality of Life Study Utilizing the EORTC QLQ-30 and EORTC QLQ-HDC29 Questionnaires for the Interview of 215 Patients Who Received Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only